Messinger Michael purchased $2K of ICU

Messinger Michael (Chief Financial Officer) purchased 2,500 shares of SeaStar Medical Holding Corp (ICU) at $0.85 on 2026-11-16.

Original reporting
SEC EDGAR · Messinger Michael
Published Nov 17, 2026, 11:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 11:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ICU
Bullish
medium confidence
Mentioned
$ICU
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICUBullishLow
01

Why it matters

The disclosure provides a fresh datapoint on insider behavior, but the transaction size is small and lacks accompanying operational or financial catalysts.

02

Market read

Traders may treat this as a minor sentiment input, not a standalone catalyst.

03

What to watch

No 10b5-1 plan is indicated, but the filing does not explain motivation; traders should avoid over-weighting insider buys without corroborating fundamentals or guidance.

Relevance 4/10Novelty 6/10Timing: filed 2026-11-17, transaction dated 2026-11-16

Background

The article is an SEC Form 4 insider transaction disclosure for SeaStar Medical Holding Corp.

Company-level read

Ticker impact

$ICUBullishMedium confidence
Context

SeaStar Medical CFO Messinger Michael bought 2,500 shares at $0.8498/share, totaling $2,124.50, per a new SEC Form 4 filing.

Expected impact

Likely limited upside bias as traders note insider buying, but magnitude is too small for a material price catalyst.

Evidence & confidence

This is an SEC Form 4 insider transaction with a low dollar value and no 10b5-1 plan disclosed; it can be sentiment-positive but typically lacks standalone market-moving force.

Market effects

No clear sector read-through from a single, small insider purchase.

None.

None.

Counterpoint

The purchase may be routine compensation-related or opportunistic timing, and the small size reduces signal quality.

Key entities

  • SeaStar Medical Holding Corp

    Company whose CFO filed an insider purchase on Form 4.

  • Messinger Michael

    Chief Financial Officer who purchased shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ICUHigh

SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates Continued adoption of the QUELIMMUNE ® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved nearly 75% enrollment in the NEUTRALIZE-AKI p